Dr. Jane Chin, President & Founder of the Medical Science Liaison (MSL) Institute appointed by the Accreditation Council for Medical Affairs (ACMA) as Chair of Scientific Advisory Board Committee

NEW YORK, March 24, 2017 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA), a leading organization within medical affairs in the pharmaceutical industry has appointed Dr. Jane Chin as the chair of a newly formed scientific advisory board. Dr. Chin will be selecting additional board members to form the first ever medical affairs think tank within the pharmaceutical industry. 

For more information about the ACMA, please visit www.medicalaffairsspecialist.org. 
Connect with us on LinkedIn or follow us on Facebook.

Dr. Chin has over a decade of experience in medical affairs and is the president founder of the MSL Institute.  Dr. Chin is considered one of the leading pioneers in the pharmaceutical industry for her seminal work in both medical affairs and the medical science liaison space. She has authored numerous articles and her work is referenced by many as the seminal source for information on the MSL role.   

"Jane brings a wealth of knowledge and expertise to the ACMA Advisory Board," said Dr. William A. Soliman, chair and founder of the ACMA.  "Jane is recognized as a leader of integrity in medical affairs and was one of the first in the industry to provide a unique perspective on the MSL role. We are excited to have her chair our scientific advisory board." 

"I have been waiting a long time to collaborate with an organization like ACMA that exemplifies medical affairs leadership and integrity," said Chin. "I am excited to be part of a think tank that brings medical affairs to the forefront of the life science industry, and have a proactive role in the next wave of this critical function."

About the ACMA:

The Accreditation Council for Medical Affairs (ACMA) provides accredited and certified programs in medical affairs. The Board Certified Medical Affairs Specialist Program (BCMAS) is the most comprehensive medical affairs program in the world and is quickly becoming recognized as the industry standard. To be eligible for the program, candidates must possess a PharmD, MD, or PhD.  Additionally, a board examination is required to successfully complete the program. 

Media Contact:

Suzanne Soliman
[email protected]  
1-646-619-3566

SOURCE Accreditation Council for Medical Affairs